Mergers & Acquisitions ·
Jin Medical International Ltd. shareholders approved several significant corporate restructuring and…
ZJYLJin Medical International Ltd.
Jin Medical International Ltd. shareholders approved several significant corporate restructuring and acquisition-related proposals on July 20, 2026. Key approvals include increasing Class B ordinary share voting rights from 30 to 800 votes per share, increasing authorized share capital to US$15,005,000, and a VIE-based acquisition of Beijing Tongsheng Technology Co., Ltd. through the issuance of 64,186,456 Class A ordinary shares at US$1.641 per share. Additionally, the company approved a share repurchase and share issuance involving Jolly Harmony Enterprises Limited. Jin Medical International Ltd. operates in the medical device industry, specializing in products for the treatment of respiratory and respiratory-related conditions.